Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Short-term Investments (2016 - 2025)

CorMedix has reported Short-term Investments over the past 10 years, most recently at $10.4 million for Q4 2025.

  • Quarterly results put Short-term Investments at $10.4 million for Q4 2025, down 6.1% from a year ago — trailing twelve months through Dec 2025 was $10.4 million (down 6.1% YoY), and the annual figure for FY2025 was $10.4 million, down 6.1%.
  • Short-term Investments reached $10.4 million in Q4 2025 per CRMD's latest filing, up from $7.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $33.3 million in Q3 2023 and bottomed at $77453.0 in Q4 2023.
  • Median Short-term Investments over the past 5 years was $10.6 million (2024), compared with a mean of $11.2 million.
  • The largest annual shift saw Short-term Investments crashed 98.76% in 2021 before it soared 19511.96% in 2024.
  • Over 5 years, Short-term Investments stood at $131567.0 in 2021, then decreased by 5.67% to $124102.0 in 2022, then plummeted by 37.59% to $77453.0 in 2023, then soared by 14149.93% to $11.0 million in 2024, then dropped by 6.1% to $10.4 million in 2025.
  • Business Quant data shows Short-term Investments for CRMD at $10.4 million in Q4 2025, $7.2 million in Q3 2025, and $31.4 million in Q2 2025.